Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

Ecopipam (EBS-101) is a first-in-class selective D1 (dopamine) receptor antagonist with Orphan Drug designation NDA acceptance is supported by positive Phase 3 data, which were published in JAMA Neurology, and Phase 2b data If approved, ecopipam would be the first new treatment option indicated for pediatric patients with Tourette syndrome in more than 10 years and […]

We haven't written up this one. Financial Post has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at financialpost.com →

More in Health & Medicine

Coffee drinkers have less fat, more muscle, and surprising hormone differences

Coffee drinkers may be getting more than an energy boost. A Finnish study found that people who drank more coffee tended to have less total and abdominal fat, more muscle, and healthier metabolic…

  • Finnish coffee drinkers have lower total and visceral body fat
  • Men with higher coffee intake have better glucose-insulin profile
  • Women with more coffee show increased SHBG and reduced free androgens

More from Wednesday 19 August →